BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma

Saved in:
Bibliographic Details
Main Authors: Katja Gutmair, Diego Villa, Nicholas Cunningham, Elisabeth Silkenstedt, Lisa Rimsza, Colleen Ramsower, David W. Scott, Alina S. Gerrie, Hanneke C. Kluin-Nelemans, Martin Dreyling, Eva Hoster
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S247395292500120X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187783200571392
author Katja Gutmair
Diego Villa
Nicholas Cunningham
Elisabeth Silkenstedt
Lisa Rimsza
Colleen Ramsower
David W. Scott
Alina S. Gerrie
Hanneke C. Kluin-Nelemans
Martin Dreyling
Eva Hoster
author_facet Katja Gutmair
Diego Villa
Nicholas Cunningham
Elisabeth Silkenstedt
Lisa Rimsza
Colleen Ramsower
David W. Scott
Alina S. Gerrie
Hanneke C. Kluin-Nelemans
Martin Dreyling
Eva Hoster
author_sort Katja Gutmair
collection DOAJ
format Article
id doaj-art-439d8e0e3d524344b1e2f133036e714e
institution OA Journals
issn 2473-9529
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series Blood Advances
spelling doaj-art-439d8e0e3d524344b1e2f133036e714e2025-08-20T02:16:02ZengElsevierBlood Advances2473-95292025-05-01992302230610.1182/bloodadvances.2024015292BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphomaKatja Gutmair0Diego Villa1Nicholas Cunningham2Elisabeth Silkenstedt3Lisa Rimsza4Colleen Ramsower5David W. Scott6Alina S. Gerrie7Hanneke C. Kluin-Nelemans8Martin Dreyling9Eva Hoster10Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilian University of Munich, Munich, GermanyDivision of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, CanadaBelfast Health and Social Care Trust, Belfast, United KingdomDepartment of Medicine III, University Hospital Ludwig Maximilian University of Munich, Munich, GermanyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZDivision of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, CanadaDivision of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, CanadaDepartment of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Medicine III, University Hospital Ludwig Maximilian University of Munich, Munich, GermanyInstitute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilian University of Munich, Munich, Germany; Correspondence: Eva Hoster, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig Maximilian University of Munich, Marchioninistr 15, 81377 Munich, Germany;http://www.sciencedirect.com/science/article/pii/S247395292500120X
spellingShingle Katja Gutmair
Diego Villa
Nicholas Cunningham
Elisabeth Silkenstedt
Lisa Rimsza
Colleen Ramsower
David W. Scott
Alina S. Gerrie
Hanneke C. Kluin-Nelemans
Martin Dreyling
Eva Hoster
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Blood Advances
title BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
title_full BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
title_fullStr BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
title_full_unstemmed BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
title_short BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
title_sort br or r chop induction with rituximab maintenance in untreated transplant ineligible patients with mantle cell lymphoma
url http://www.sciencedirect.com/science/article/pii/S247395292500120X
work_keys_str_mv AT katjagutmair brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT diegovilla brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT nicholascunningham brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT elisabethsilkenstedt brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT lisarimsza brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT colleenramsower brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT davidwscott brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT alinasgerrie brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT hannekeckluinnelemans brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT martindreyling brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma
AT evahoster brorrchopinductionwithrituximabmaintenanceinuntreatedtransplantineligiblepatientswithmantlecelllymphoma